Publication:
Risk assessment using heart rate variability due to methylphenidate treatment in children with attention deficit hyperactivity disorder

dc.contributor.authorsArman, Ayse Rodopman; Yilmaz, Seheryeli; Carkaxhiu, Gresa; Soysal, Dilek; Akalin, Figen
dc.date.accessioned2022-03-10T17:51:34Z
dc.date.accessioned2026-01-11T06:22:12Z
dc.date.available2022-03-10T17:51:34Z
dc.date.issued2013
dc.identifier.doidoiWOS:000209547900565
dc.identifier.eissn1435-165X
dc.identifier.issn1018-8827
dc.identifier.urihttps://hdl.handle.net/11424/221497
dc.identifier.wosWOS:000209547900565
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofEUROPEAN CHILD & ADOLESCENT PSYCHIATRY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMethylphenidate
dc.subjecttreatment
dc.subjectADHD
dc.subjectheart rate variability (HRV)
dc.titleRisk assessment using heart rate variability due to methylphenidate treatment in children with attention deficit hyperactivity disorder
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS303
oaire.citation.startPageS302
oaire.citation.titleEUROPEAN CHILD & ADOLESCENT PSYCHIATRY
oaire.citation.volume22

Files